Magnera (MAGN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
20 Nov, 2025Executive summary
Achieved $839 million in Q4 sales and $3.2 billion full-year revenue, with adjusted EBITDA of $362 million and $126 million free cash flow, exceeding 30% yield; record cash flow from operations and significant debt repayment were also reported.
Strategy to lead in advanced specialty materials and business optimization through Project CORE and post-merger integration delivered market share gains, product mix improvements, and synergy execution.
Completed stabilization phase post-merger, now entering optimization with integrated commercial teams and standardized processes, with continued innovation in sustainable products.
Financial highlights
Q4 adjusted EBITDA was $90 million, flat sequentially but up 36% year-over-year, with strong cash flow exceeding guidance.
FY 2025 revenue was $3,204 million, adjusted EBITDA $354 million, and free cash flow $126 million, representing over 30% yield at year-end.
Year-end leverage stood at 3.8x, with $600 million in available liquidity and $305 million in cash and equivalents.
Outlook and guidance
Fiscal 2026 guidance: adjusted EBITDA of $380–$410 million, free cash flow of $90–$110 million, and capital expenditures of $80 million, including $10 million for IT.
Targeting ~9% earnings improvement in 2026, driven by synergy realization, Project CORE, and cost/capacity optimization.
Volume expected to be flat overall, with margin expansion from synergies and cost initiatives; South America and Europe softness to impact early quarters.
Latest events from Magnera
- All proposals passed, directors elected, and no shareholder questions were raised.MAGN
AGM 20269 Mar 2026 - Net sales up 13% to $792M, adjusted EBITDA up 11%, and 2026 guidance reaffirmed.MAGN
Q1 20265 Feb 2026 - Proxy covers director elections, auditor ratification, executive pay, and strong ESG focus.MAGN
Proxy filing14 Jan 2026 - Votes on directors, auditor ratification, and executive pay are set for the 2026 meeting.MAGN
Proxy filing14 Jan 2026 - Q1 sales rose 35% to $702M post-merger, with EBITDA up 8% and widened losses from integration costs.MAGN
Q1 202523 Dec 2025 - Strong Q4, raised 2026 outlook, and innovation drive global growth and operational excellence.MAGN
BofA Securities Leveraged Finance Conference 20253 Dec 2025 - Net sales hit $839M, EBITDA $91M; merger and cost initiatives offset market softness.MAGN
Q3 202523 Nov 2025 - Q2 sales up 48% to $824M on merger, but net loss and lower EBITDA guidance issued.MAGN
Q2 202521 Nov 2025 - Synergy realization and operational optimization drive growth and margin recovery into 2027.MAGN
Wells Fargo Industrials & Materials Conference 202510 Nov 2025